Wealthspring Capital LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 14 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealthspring Capital LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$1,306,000
+1.3%
130,290
+0.2%
0.26%
+6.6%
Q2 2022$1,289,000
-5.6%
130,072
-6.0%
0.24%
-9.7%
Q1 2022$1,365,000
+9.4%
138,373
+10.6%
0.27%0.0%
Q4 2021$1,248,000
+0.2%
125,064
-0.5%
0.27%
-11.0%
Q3 2021$1,246,000
+4.4%
125,700
+7.4%
0.30%
+0.7%
Q2 2021$1,194,000
+1.4%
117,0540.0%0.30%
-6.3%
Q1 2021$1,177,000
-15.0%
117,054
-9.9%
0.32%
-53.6%
Q4 2020$1,385,000129,8800.69%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q3 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 248,674$2,452,0000.81%
Wealthspring Capital LLC 138,373$1,365,0000.27%
Cowen Investment Management LLC 100,000$986,0000.21%
Integrity Capital Management (HK) Ltd 3,800$37,0000.19%
Sage Mountain Advisors LLC 94,640$933,0000.15%
Schechter Investment Advisors, LLC 82,802$816,0000.08%
Verition Fund Management LLC 397,603$3,928,0000.05%
Magnetar Financial LLC 450,000$4,446,0000.05%
HGC Investment Management Inc. 79,150$781,0000.05%
RIVERNORTH CAPITAL MANAGEMENT, LLC 75,650$747,0000.03%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders